Back to Search
Start Over
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy
- Source :
- Gastroenterology, Gastroenterology, WB Saunders, 2019, 156 (4), pp.997-1009.e5. ⟨10.1053/j.gastro.2018.11.053⟩, Gastroenterology, Elsevier, 2019, 156 (4), pp.997-1009.e5. ⟨10.1053/j.gastro.2018.11.053⟩
- Publication Year :
- 2019
- Publisher :
- HAL CCSD, 2019.
-
Abstract
- International audience; Background & aims: Management of patients with cirrhosis includes endoscopic screening and surveillance to detect esophageal varices (EV) and prevent bleeding. However, the Baveno VI guidelines recommend avoiding endoscopies for patients with liver stiffness measurements below 20 kPa and platelet counts above 150,000 (favorable Baveno VI status) and endoscopic assessment of patients with higher levels of liver stiffness and platelet counts (unfavorable Baveno VI status). We aimed to validate the Baveno VI guidelines, evaluating outcomes of patients in the ANRS-CO12 CirVir cohort with compensated cirrhosis associated with hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, with or without a sustained response to antiviral therapy.Methods: We performed an ancillary study using data from 891 patients in the ANRS CO12 CirVir cohort, treated at 35 centers in France, with HCV or HBV infection and biopsy-proven cirrhosis, Child-Pugh A scores, no previous complications, and no hepatocellular carcinoma who underwent an endoscopic procedure and had interpretable liver stiffness measurements and platelet counts. Progression of portal hypertension (PHT) was defined as the onset of varices needing treatment (VNT) or PHT-related bleeding. An sustained response to antiviral therapy was defined as undetectable level of HCV RNA by polymerase chain reaction assay (
- Subjects :
- Liver Cirrhosis
Male
0301 basic medicine
Cirrhosis
Sustained Virologic Response
MESH: Sustained Virologic Response
MESH: Elasticity Imaging Techniques
medicine.disease_cause
Gastroenterology
Endoscopy, Gastrointestinal
0302 clinical medicine
Esophageal varices
MESH: Practice Guidelines as Topic
Interquartile range
Mass Screening
MESH: Middle Aged
medicine.diagnostic_test
Portal Hypertension
Middle Aged
MESH: Endoscopy, Gastrointestinal
MESH: Hepatitis C, Chronic
Survival Rate
Population Surveillance
Hepatocellular carcinoma
Practice Guidelines as Topic
Disease Progression
Elasticity Imaging Techniques
Female
030211 gastroenterology & hepatology
MESH: Disease Progression
Variceal Bleeding
MESH: Liver Cirrhosis
MESH: Antiviral Agents
medicine.medical_specialty
MESH: Survival Rate
MESH: Hepatitis B, Chronic
Hepatitis C virus
Esophageal and Gastric Varices
Antiviral Agents
MESH: Population Surveillance
03 medical and health sciences
Elastometry
MESH: Esophageal and Gastric Varices
Hepatitis B, Chronic
Esophagus
Internal medicine
Hypertension, Portal
medicine
Humans
MESH: Mass Screening
MESH: Platelet Count
Hepatitis B virus
Prothrombin time
MESH: Hypertension, Portal
MESH: Humans
Hepatology
Platelet Count
business.industry
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
Hepatitis C, Chronic
medicine.disease
digestive system diseases
MESH: Male
030104 developmental biology
business
Varices
MESH: Female
Subjects
Details
- Language :
- English
- ISSN :
- 00165085 and 15280012
- Database :
- OpenAIRE
- Journal :
- Gastroenterology, Gastroenterology, WB Saunders, 2019, 156 (4), pp.997-1009.e5. ⟨10.1053/j.gastro.2018.11.053⟩, Gastroenterology, Elsevier, 2019, 156 (4), pp.997-1009.e5. ⟨10.1053/j.gastro.2018.11.053⟩
- Accession number :
- edsair.doi.dedup.....a904483836ff1e9205faf9bdfe473559